According to the World Health Organization, non-communicable diseases (NCDs) make up over 60% of the deaths worldwide, many of which occur before the age of 70. Cardiovascular diseases are the most critical NCDs worldwide with diabetes as a major cardiovascular risk factor. Cardiovascular diseases impose medical, social and public health problems that increase the economic burden on patients, healthcare systems and national economies. Pharmacists have an important role to play as part of a multidisciplinary healthcare team approach focused on the prevention, early detection, disease state management and optimisation of therapy regimens.

Learning objectives:

• To get an overview of the different roles that pharmacists can play in the management of cardiovascular diseases in terms of prevention, screening, patient referral, disease state management and treatment optimisation
• To learn about the FIP reference paper on NCDs launched in April (including selected international best practices/examples)
• To develop the knowledge and skills for developing professional services in this area.

According to the World Health Organization, non-communicable diseases (NCDs) make up over 60% of the deaths worldwide, many of which occur before the age of 70. Cancer of all types is of tremendous concern globally. Expanding preventative measures by addressing risk factors and adequate screening is of utmost importance to reduce incidence rates and improve survival rates. In addition Pharmacotherapy for treatment of cancer is often complex, with many medication-related adverse events.

Cancer treatment frequently results in the prescribing of additional therapy to manage adverse effects, including short-term and long-term therapies for gastrointestinal, dermatological, neurological, psychological, and endocrinological adverse effects. Both community and hospital pharmacists can play important and complementary roles in cancer prevention, screening and treatment optimisation. These will be described in this webinar.

Learning objectives:

• To get an overview of the different roles that community and hospital pharmacists can play in the management of cancer in terms of prevention, screening, patient referral, disease state management and treatment optimisation
• To learn about the FIP reference paper on NCDs launched in April (including selected international best practices/examples)
• To develop the knowledge and skills for developing professional services in this area.